Literature DB >> 16157254

A robustified modeling approach to analyze pediatric length of stay.

Andy H Lee1, Michael Gracey, Kui Wang, Kelvin K W Yau.   

Abstract

PURPOSE: Length of stay (LOS) is an important measure of the cost of pediatric hospitalizations, but the guidelines developed so far are not rigorously evidence-based. This study demonstrates a robust gamma mixed regression approach to analyze the positively skewed LOS variable, which has implications for future studies of pediatric health care management.
METHODS: The robustified approach is applied to analyze hospital discharge data on childhood gastroenteritis in Western Australia (n=514). The model accounts for demographic characteristics and co-morbidities of the patients, as well as the dependency of LOS outcomes nested within the 58 hospitals in the State. The method is compared with the standard linear mixed regression with trimming of extreme observations.
RESULTS: For the empirical application, the linear mixed regression results are sensitive to the magnitude of trimming. The identified significant factors from the robust regression model, namely infection, failure to thrive, and iron deficiency anemia are resistant to high-LOS outliers.
CONCLUSIONS: Robust gamma mixed regression appears to be a suitable alternative to analyze the clustered and positively skewed pediatric LOS, without transforming and trimming the data arbitrarily.

Entities:  

Mesh:

Year:  2005        PMID: 16157254     DOI: 10.1016/j.annepidem.2004.10.001

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  13 in total

1.  Analysis of HIV/AIDS DRG in Portugal: a hierarchical finite mixture model.

Authors:  Sara Simões Dias; Valeska Andreozzi; Rosário O Martins
Journal:  Eur J Health Econ       Date:  2012-08-05

2.  EM for regularized zero-inflated regression models with applications to postoperative morbidity after cardiac surgery in children.

Authors:  Zhu Wang; Shuangge Ma; Ching-Yun Wang; Michael Zappitelli; Prasad Devarajan; Chirag Parikh
Journal:  Stat Med       Date:  2014-09-26       Impact factor: 2.373

3.  Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood.

Authors:  Samir S Shah; Matthew Hall; Jason G Newland; Thomas V Brogan; Reid W D Farris; Derek J Williams; Gitte Larsen; Bryan R Fine; James E Levin; Jeffrey S Wagener; Patrick H Conway; Angela L Myers
Journal:  J Hosp Med       Date:  2011-03-03       Impact factor: 2.960

4.  Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis.

Authors:  Z D Mulla; S G Gibbs; D M Aronoff
Journal:  Epidemiol Infect       Date:  2006-11-03       Impact factor: 2.451

5.  Length of stay and imminent discharge probability distributions from multistage models: variation by diagnosis, severity of illness, and hospital.

Authors:  Gary W Harrison; Gabriel J Escobar
Journal:  Health Care Manag Sci       Date:  2010-09

6.  Non-psychiatric hospitalization length-of-stay for patients with psychotic disorders: A mixed methods study.

Authors:  Guy M Weissinger; J Margo Brooks Carthon; Bridgette M Brawner
Journal:  Gen Hosp Psychiatry       Date:  2020-07-31       Impact factor: 3.238

7.  Abdominal Surgery Impact Scale (ASIS) is responsive in assessing outcome following IPAA.

Authors:  Indraneel Datta; Brenda O'Connor; J Charles Victor; David R Urbach; Robin S McLeod
Journal:  J Gastrointest Surg       Date:  2009-01-16       Impact factor: 3.452

8.  A review of statistical estimators for risk-adjusted length of stay: analysis of the Australian and new Zealand Intensive Care Adult Patient Data-Base, 2008-2009.

Authors:  John L Moran; Patricia J Solomon
Journal:  BMC Med Res Methodol       Date:  2012-05-16       Impact factor: 4.615

9.  Length of Hospital Stay Prediction at the Admission Stage for Cardiology Patients Using Artificial Neural Network.

Authors:  Pei-Fang Jennifer Tsai; Po-Chia Chen; Yen-You Chen; Hao-Yuan Song; Hsiu-Mei Lin; Fu-Man Lin; Qiou-Pieng Huang
Journal:  J Healthc Eng       Date:  2016       Impact factor: 2.682

10.  Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials.

Authors:  Robert B M Landewé; Carol A Connell; John D Bradley; Bethanie Wilkinson; David Gruben; Sander Strengholt; Désirée van der Heijde
Journal:  Arthritis Res Ther       Date:  2016-09-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.